SKLB-023

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameSKLB-023
Drug Alias NameSKLB-023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase, inducible inhibitors
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsInflammationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China Hospital Of Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsInflammationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A